Patrick J Mcenany Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Patrick J Mcenany is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 4.48 Million shares of CPRX, which is worth approximately $91.8 Million. The most recent transaction as insider was on Aug 22, 2024, when has been sold 5,100 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.48M

1.11% 3M change

8.71% 12M change

Total Value Held $91.8 Million

PATRICK J MCENANY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 22 2024	SELL Bona fide gift	-	5,100 Reduced 0.11%	4,478,169 Common Stock, par valu...
Aug 15 2024	SELL Bona fide gift	-	45,000 Reduced 0.99%	4,483,269 Common Stock, par valu...
Jan 30 2024	BUY Exercise of conversion of derivative security	-	143,000 Added 3.06%	4,528,256 Common Stock, par valu...
Jan 02 2024	BUY Exercise of conversion of derivative security	$282,500 $1.13 p/Share	250,000 Added 5.39%	4,385,256 Common Stock, par valu...
Dec 27 2023	SELL Payment of exercise price or tax liability	-	10,362 Reduced 0.25%	4,135,256 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	26,333 Added 0.63%	4,145,618 Common Stock, par valu...
May 16 2023	BUY Exercise of conversion of derivative security	$137,340 $0.79 p/Share	173,849 Added 4.05%	4,119,285 Common Stock, par valu...
May 15 2023	SELL Open market or private sale	$345,977 $13.23 p/Share	26,151 Reduced 0.66%	3,945,436 Common Stock, par valu...
May 15 2023	BUY Exercise of conversion of derivative security	$20,659 $0.79 p/Share	26,151 Added 0.65%	3,971,587 Common Stock, par valu...
Feb 15 2023	SELL Payment of exercise price or tax liability	-	14,204 Reduced 0.36%	3,945,436 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	58,333 Added 1.45%	3,959,640 Common Stock, par valu...
Dec 29 2022	SELL Bona fide gift	-	10,000 Reduced 0.26%	3,901,307 Common Stock, par valu...
Dec 28 2022	SELL Bona fide gift	-	10,000 Reduced 0.26%	3,911,307 Common Stock, par valu...
Dec 06 2022	SELL Payment of exercise price or tax liability	-	12,133 Reduced 0.31%	3,921,307 Common Stock, par valu...
Dec 06 2022	BUY Exercise of conversion of derivative security	-	30,834 Added 0.78%	3,933,440 Common Stock, par valu...
Nov 21 2022	SELL Open market or private sale	$2,299,500 $15.33 p/Share	150,000 Reduced 3.7%	3,902,606 Common Stock, par valu...
Nov 21 2022	BUY Exercise of conversion of derivative security	$336,000 $2.24 p/Share	150,000 Added 3.57%	4,052,606 Common Stock, par valu...
Nov 18 2022	SELL Open market or private sale	$5,467,000 $15.62 p/Share	350,000 Reduced 8.23%	3,902,606 Common Stock, par valu...
Nov 18 2022	BUY Exercise of conversion of derivative security	$784,000 $2.24 p/Share	350,000 Added 7.6%	4,252,606 Common Stock, par valu...
Sep 14 2022	SELL Open market or private sale	$14,590,897 $15.41 p/Share	946,846 Reduced 19.52%	3,902,606 Common Stock, par valu...
Sep 13 2022	SELL Open market or private sale	$1,238,127 $15.33 p/Share	80,765 Reduced 1.64%	4,849,452 Common Stock, par valu...
Aug 19 2022	SELL Open market or private sale	$1,762,500 $14.1 p/Share	125,000 Reduced 2.47%	4,930,217 Common Stock, par valu...
Aug 19 2022	BUY Exercise of conversion of derivative security	$316,250 $2.53 p/Share	125,000 Added 2.41%	5,055,217 Common Stock, par valu...
Aug 18 2022	SELL Open market or private sale	$2,439,500 $13.94 p/Share	175,000 Reduced 3.43%	4,930,217 Common Stock, par valu...
Aug 18 2022	BUY Exercise of conversion of derivative security	$316,250 $2.53 p/Share	125,000 Added 2.45%	4,980,217 Common Stock, par valu...

PJM

Patrick J Mcenany

Director

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account